domingo, 6 de octubre de 2024

Clinical symptoms and psychosocial functioning in patients with schizophrenia spectrum disorders testing seropositive for anti-NMDAR antibodies: a case–control comparison with patients testing negative

https://www.thelancet.com/journals/lanpsy/article/PIIS2215-0366(24)00249-9/abstract?utm_campaign=update-lanpsy&utm_medium=email&dgcid=hubspot_update_feature_updatealerts_lanpsy&_hsenc=p2ANqtz-_kAcuqWMr6XB4_2GQ5TC-5hYguArvnfgJMFTzlLIUJTj9BwHjrdd9sjfIGsMpYVQSy-EHVqVIMy56wSlNHPkDS1FKznA&_hsmi=327352080&utm_content=327302475&utm_source=hs_email

No hay comentarios:

Publicar un comentario